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 Persistent infection (PI) with Bovine Viral Diarrhea Virus (BVDV) is a major 
source of economic loss for the livestock industry. Persistent infection occurs when a 
dam is exposed to the virus during 42 to 125 days of gestation and the virus is passed to 
the fetus without an adaptive immune response. These PI calves serve as continuous 
sources of infection to others. The identification of differences in expression of gene 
networks and/or genetic markers associated with infection could assist in the 
development of novel strategies to prevent, control, or treat BVDV. To examine the host 
response to PI, RNA-Seq data were obtained from blood of cattle naturally infected and 
PI with BVDV strains 1a (n=10), 1b (n=8), and 2 (n=8). Additional data were collected 
from two comparison groups, a high exposure group with one positive test for the virus 
that were later confirmed negative for PI (n=9), and an unexposed group from a closed 
herd (n=10). Sequencing on an Illumina NextSeq resulted in 58 million stranded paired-
end reads per animal which were aligned to the UMD3.1 bovine genome. With 86% of 
the reads aligning and the quantification of 22,915 transcripts, differential expression 
analyses revealed there were no significant differentially expressed transcripts between 
the strain subtypes and among the strains of PI cattle. There were 1,032 differentially 
expressed transcripts between the PIs and the high exposure group; this is the comparison 
that was focused on in further analyses. The differential expression data were examined 
 
 
for gene network relationships. The top significant canonical pathways represented by the 
expression data were interferon signaling and activation of interferon response factors by 
cytosolic pattern recognition receptors. There were significant predictions of decreased 
replication of viruses and decreased risk of viral infection for the BVDV-PIs. These 
results suggest that the BVDV-PIs may have an innate immune response to BVDV since 
the directionality of their gene expression supports the presence of a viral infection when 
compared to high exposure animals. 
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CHAPTER I: A LITERATURE REVIEW 
History of Bovine Viral Diarrhea Virus 
In 1946, Bovine Viral Diarrhea Virus was first described as an acute, contagious, 
and transmissible disease in cattle after an outbreak in a large dairy herd in New York. It 
was characterized by many clinical symptoms including severe diarrhea, weight loss, 
abortions, and a 4-8% mortality rate (Olafson et al., 1946). In the same year in 
Saskatchewan, Canada, “X disease” was described as having similar symptoms as the 
severely infected cattle in New York. Collectively these diseases from New York and 
Canada became known as virus diarrhea of cattle (Goens, 2002). In the 1950s Iowa State 
University started to observe cases of illness similar to virus diarrhea, yet they believed 
they were observing a new disease due to differences in nasal discharge, reoccurrence, 
and gross lesions (Underdahl et al., 1957). This differentiated disease was termed 
mucosal disease. It wasn’t until the 1960s that enough similarities between virus diarrhea 
and mucosal disease were observed that a consensus was formed that they were in fact 
the same disease with minor variations. It became known as bovine viral diarrhea-
mucosal disease complex (Jubb, 1985).  
In the early 1990s, mucosal disease and BVDV were studied in depth to 
specifically classify each disease. Mucosal disease was discovered to occur only in PI 
cattle after a second infection of a cytopathic strain, genetically similar to the initial non-
cytopathic, appeared; the combination of the two viruses is observed to cause more 
severe disease than either one alone (Sopp et al., 1994; Bolin, 1995). After several major 
hemorrhagic outbreaks in the 1980s and 1990s across the world, it appeared that there 
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was more variation in virulence of the non-cytopathic biotype resulting in the need of 
advanced techniques to classify the various BVDV strains. 
Studies of experimental infections in pregnant cattle and neonatal calves 
discovered that congenitally infected calves would be persistently infected (PI) and 
would not produce antibodies against the virus, but it wasn’t until the discovery of a two 
year old PI bull that the idea of PI while still being immunocompetent was widely 
accepted (Johnson and Muscoplat, 1973; Coria and McClurkin, 1978). Only non-
cytopathic strains of the virus possess the ability to cause PI, and window for infection is 
limited to 42-125 days of gestation (McClurkin et al., 1984; Brownlie et al., 1989).  
These PI animal serve as a constant source for infection for any cattle that they may come 
into contact with directly or indirectly since they constantly shed the virus for their entire 
life (McClurkin et al., 1984). 
 
Detection of Persistent Infection 
Calves can have a transient, acute infection or PI of BVDV. In order to determine 
the difference, multiple tests must be completed. The initial test for infection utilizes an 
antigen capture Enzyme-Linked Immunosorbent Assay (ELISA). An ELISA contains 
antibodies specific to a pathogen attached to a plastic surface. An antigen sample is added 
and if the correct antigen is present they will bind to the antibodies. Next a second 
antibody with a marker is added and if there is a positive reaction the marker will have a 
visible color change. This test can also be utilized for testing for the presence of 
antibodies, but since persistent infection results in the absence of antibodies the version 
testing for the presence of the virus is used. An acute infection clears the system 
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approximately in two weeks so suspected persistent infection requires retesting after a 
minimum of three weeks. In order to avoid possible bias from utilizing the same test, 
persistent infection can be confirmed with immunohistochemistry or PCR.  
Immunohistochemistry is a process of detecting antigens in cells of a tissue 
section through a color change. With a similar process to an ELISA, the color change is 
achieved through an antibody conjugated to an enzyme that catalyzes a color reaction 
through staining or by a fluorescent tag on the antibody. With PI, the antigen is 
embedded deeper within the tissues while in an acute infection the antigen is localized to 
specific areas. PCR will amplify highly conserved sequences of the antigens genome to 
high levels for detection of the virus, if there is no amplification, the virus is not present. 
Initial detection followed by a positive second detection after a minimum of three weeks 
identifies persistent infection rather than an acute infection. 
 
Virus Taxonomy 
BVDV strains are divided between two biotypes, cytopathic and non-cytopathic, 
based on their behavior in cell culture and arrangement differences of the non-structural 
NS3/p80 gene (Baker, 1987; Meyers and Thiel, 1996). Expression of the NS3 protein 
either by introduction of a cleavage site into the NS2/3 gene or by duplication of the NS3 
protein coding sequence of a non-cytopathic biotype can induce a biotype switch to 
cytopathic (Donis and Dubovi, 1987). When by recombination or rearrangement a 
cleavage site is introduced into the NS3/p80 protein gene, a non-cytopathic strain mutates 
into a cytopathic strain which results in mucosal disease due to co-infection of the two 
biotypes (Donis, 1995; Fritzemeier et al., 1997). The cytopathic biotype induces 
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cytoplasmic vacuolation and results in cell death two to three days after inoculation of 
cell cultures (Lee and Gillespie, 1957; Gillespie et al., 1960). The non-cytopathic biotype 
can be isolated from acute infections and is the only biotype that can establish PI (Liess et 
al., 1974; McClurkin et al., 1984). When bovine fetuses were challenged with a 
cytopathic strain during 63 and 107 days of gestation no PIs were established supporting 
only non-cytopathic strains can establish PI (Brownlie et al., 1989). Greater than 90% of 
infections, persistent or acute, are identified to be originating from the non-cytopathic 
biotype (Dubovi, 1992). The high infectious rate is due to the greater volume of nasal 
shedding of non-cytopathic strains as compared to cytopathic strains, and because the 
main vector of infection is through the respiratory tract (Ohmann, 1983; Wentink et al., 
1991; Lambot et al., 1998). On the other hand, the cytopathic biotype is uncommon and 
is most commonly isolated from fatal cases of mucosal disease when a persistent non-
cytopathic strain mutates and gives rise to a homologous cytopathic strain (Brownlie et 
al., 1987; Howard et al., 1987; Moennig et al., 1990).   
BVDV originally was placed within the Togaviridae family, but due to the 
similarities in genome organization and methods of replication the virus was reclassified 
as a Flaviviridae pestivirus (Westaway et al., 1985; Collett et al., 1988; Collett et al., 
1991; Horzinek et al., 1991). Pestiviruses are nonsegmented, single-stranded, sense RNA 
viruses. The genome of BVDV consists of 1 open reading frame flanked by 2 
untranslated regions and is approximately 12.3 kilobases (Kuta et al., 2015). The first 
protein, Npro, is a viral protease followed by the structural protein genes, capsid, and 
three envelope glycoproteins at the 5’ end of the open read frame. These are then 
followed by six nonstructural protein genes on the non-cytopathic genome: NS2/3, 4A, 
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4B, 5A, and 5B (Donis, 1995). Viral gene expression occurs via synthesis of a 
polyprotein with subsequent proteolytic processing mediated by cellular and viral 
proteases (Collett et al., 1988; Wiskerchen et al., 1991; Wiskerchen and Collett, 1991; 
Rümenapf et al., 1993; Thiel et al., 1993). One of the highly variable regions in the 
BVDV genome is the E2 region which produces a protein that elicits an antibody 
response (Donis, 1995). On the other hand, the 5’ untranslated region (UTR) is highly 
conserved since it serves the purpose of starting translation for the open reading frame 
(ORF); it is also based on this region that two major subtypes of BVDV, BVDV1 and 
BVDV2, are distinguished (Ridpath et al., 1994).  
BVDV2 was first classified in 1994 after the death of 25% of all of the veal calves 
in Quebec in 1993. With a 30% difference in the 5’ UTR sequence compared to the 
BVDV1 strains but maintaining the same secondary structure with serological 
crossreactivity, BVDV was split into two groups: BVDV1 and the new strain BVDV2 
(Pellerin et al., 1994). Comparisons of BVDV genomes results in 70% or less sequence 
similarities between BVDV1 and BVDV2 when comparing the 5’ UTR while the 
subtypes of each strain share at least 88% sequence (Ridpath et al., 1994; Ridpath and 
Bolin, 1995). The general rate of divergence for RNA viruses is estimated to be 0.03-
2.0% per nucleotide per year, this rate along with the replication rate can give rise to a 
plethora of genetically variable virus within a single host (Strauss et al., 1996). The 
subtypes of each strain are named sequentially with letters. For instance, seventeen 
BVDV1 subtypes have been identified and are recognized as BVDV1a to BVDV1q.  
Only three BVDV2 subtypes have been recognized, and recently, a third strain, BVDV3, 
has been identified and termed HoBi-like virus (Luzzago et al., 2014).  
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Point mutations and deletions are extremely common in BVDV due to viral 
polymerases which lack the ability to proofread and correct errors during replication. 
Additionally, recombination can occur between the host and the virus when host RNA 
sequences are inserted into viral genome. Without the p80 gene, which controls the 
cytopathicity of the virus, BVDV2 can cause severe hemorrhagic syndrome (Bolin and 
Ridpath, 1992; Ridpath and Bolin, 1995).  
While the two main genotypes have been identified worldwide the subtypes are 
geographically segregated. The three major subtypes circulating within the United States 
are BVDV1a, 1b, and 2a. A complete genome sequencing study was conducted by 
Workman et al. (2016) in order to identify the prevalence of current subtypes within the 
central United States and investigate genetic variation among the viruses. Nineteen de 
novo BVDV genomes were assembled by RNA sequencing from plasma collected from 
confirmed PI calves. The complete coding sequences along with the 5’ UTR sequences 
were compared to 75 full length BVDV genomes available in GenBank. For the BVDV1 
subtypes there were no phylogenetic differences between the 5’ UTR and complete 
coding sequence classifications. Meanwhile, phylogenetic analysis of the complete 
coding sequences resulted in more distinct genetic classification of the BVDV2 subtypes. 
From the Workman et al. (2016) study classification based on 5’ UTR analyses alone 
may not be enough to provide correct identification of virus subtypes crucial for 
vaccination protocols and eradication efforts. 
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Economical Impact 
Bovine Viral Diarrhea Virus has widespread economic impacts on the cattle 
industry across the world. In dairy and beef production, 2.7% of randomly selected herds 
in the United States have confirmed PI calves, and 7% of the dams of PI calves were 
confirmed to be PI themselves (Wittum et al., 2001). Feedlot prevalence of BVDV PI has 
been identified to range from 0.3% to 2.6% (Loneragan et al., 2005; Hessman et al., 
2009). Economically, $93.52/animal is lost for exposure to PI cattle of which 
$88.26/animal is attributed to performance losses and the remaining $5.26/animal results 
from an increase in fatality percentage. Outbreaks in the dairy industry alone can cause 
losses of $40,000 to $100,000 per herd due to mortality, decreased milk production, and 
abortions (Carman et al., 1998). At the population level, losses are estimated at $10-57 
million per 1 million calvings in the US alone (Houe, 1999). 
Performance loss is a major factor in profitability of the cattle industry. The goal 
of the beef industry is to produce calves that have reached a certain weight for slaughter, 
but when an animal is placed under stress by an acute or PI their performance suffers as 
the process of energy storage shifts to energy metabolism. PI calves weigh around 73.5 
kg less than non-PI calves at weaning due to secondary infections (Waldner and 
Kennedy, 2008).  Unexposed cattle convert feed into body weight 55% more efficiently 
than cattle who have direct exposure to PI calves (Hessman et al., 2009).  Non-PI cattle 
exposed to PI cattle have significantly lower weight gain and average daily gain, and 
have significantly higher F:G ratios than unexposed non-PI cattle (Hessman et al., 2009; 
Grooms et al., 2014). Calves with antibody titers above 1,000 against BVDV1 and 
BVDV2 weigh 13-15 kg less than calves with lower titers (O'Connor et al., 2001; 
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Waldner and Kennedy, 2008). The mean cost of gain for direct exposure to PI cattle is 
two times higher than cost of gain for unexposed cattle (Hessman et al., 2009). Out of all 
of the PI cattle in feedlots 10.8% are determined to be chronically ill and sold for salvage 
slaughter as compared with 3.6% of the non-PI cattle. With the decrease in performance 
to the point of the animals considered for salvage, the effects of BVDV-PI animals spread 
beyond themselves and to the entire feedlot. 
PI cattle are at a greater risk of chronic illness due to the synergetic effects of PI 
and they will need to be repeatedly treated for health concerns as compared to non-PI 
cattle (Hessman et al., 2009). The odds of treatment of a PI calf is approximately 6.3 
times that of a non-PI calf, and the number of total treatments is about 3.1 times higher 
for PI calves (Waldner and Kennedy, 2008). Non-PI cattle, vaccinated and unvaccinated, 
exposed to PI cattle have almost 6 times higher the incidence rate of an additional 
treatment when compared to non-exposed cattle (Grooms et al., 2014). Treatments for 
respiratory tract diseases were 43% greater in feedlot cattle who had opportunity for 
direct contact with a PI animal, and 15.9% of initial treatments for respiratory tract 
diseases were attributed to exposure to a PI animal (Loneragan et al., 2005). The need to 
treat an animal multiple times with antibiotics increases costs, stress on the animal, and 
has the potential to contribute to increasing antibiotic resistant pathogens.  
Due to the immunosuppressant effects of BVDV, PI cattle have higher mortality 
rates than non-PI cattle, however even exposure to PI cattle can increase the mortality 
rate of non-PI herd mates. The risk of calf death is higher in herds in which at least one PI 
calf is identified as compared to herds with no PI calves, and this risk increases with the 
continual presence of a PI calf (Waldner and Kennedy, 2008). This effect is compounded 
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in a feedlot environment where cattle from multiple sources are gathered at a single 
location in close proximity. In feedlots, PI cattle have a fatality chance 23.2% higher than 
non-PI cattle, but even exposure, direct or indirect, to a PI animal increases the chances 
of having at least 1 fatality in a feedlot by a factor of 4 (Hessman et al., 2009). Non-PI 
cattle, vaccinated and unvaccinated, exposed to PI cattle have double the incidence rate 
of morbidity as compared to non-exposed cattle (Grooms et al., 2014). Overall, feedlot 
postmortem examinations have identified that 2.5% of all deaths were attributed to the 
presence of a BVDV PI individual (Loneragan et al., 2005).    
 
Genetic Understandings 
 Gaining an understanding of the genetic interactions between infected cattle and 
BVDV will allow for further development of eradication efforts through genetic testing 
and selective breeding, and potentially lead to new therapeutic targets. The difference in 
establishing PI between cytopathic and non-cytopathic biotypes has been identified as an 
area which needs further exploration. Unlike cytopathic strains, non-cytopathic strains do 
not induce type one interferons in vitro. It has been proposed that the absence of an 
interferon response of the host is what allows non-cytopathic strains to develop into PIs 
(Diderholm and Dinter, 1966; Nakamura et al., 1995; Adler et al., 1997). Charleston et al. 
(2001) detected non-cytopathic BVDV in both the amniotic fluid and fetal spleen while 
cytopathic BVDV was only detectable in the fetal spleen. These results suggest that the 
fetus has a mechanism in place to limit viral replication of cytopathic strains but has no 
control against non-cytopathic strains. Investigating further, Charleston et al. (2001) 
confirmed that fetuses had minimal to no production of type one interferons in response 
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to non-cytopathic strains but postnatal did produce a response, and cytopathic strains 
produced a response at all time points. Based on these findings there is an interaction 
between the virus and the host which allows for the establishment of PI by non-
cytopathic strains that needs to be further researched. 
 Estimates for heritability for bovine respiratory disease (BRD) resistance range 
from 0.10 to 0.48 depending on the breed composition and age of the cattle (Muggli-
Cockett et al., 1992; Snowder et al., 2005, 2006; Heringstad et al., 2008). Heritability 
estimates for BVDV-PI have not been reported; however BVDV is included in the 
complex of viruses that make up BRD and therefore the estimates for BRD resistance 
account for a portion of BVDV-PI (Neibergs et al., 2011). A study conducted by 
Neibergs et al. (2011) examined loci linked with BRD complex through a genome wide 
linkage study of microsatellites. The authors then determined if these same loci were 
associated with PI of BVDV. This approach was taken due to identification of over 65% 
of BRD complex infections being co-infected with BVDV (Fulton et al., 2000). The two 
pathogens are often identified together due to the immunosupression created by BVDV 
which allows for a synergistic relationship with BRD pathogens (Campbell, 2004). 
Utilizing a Brahman x Hereford sire half-sib family to capture Bos indicus and Bos taurus 
influence respectively, linkage analyses suggested two quantitative trait loci (QTL) on 
chromosome 2 and 26. With additional microsatellite markers evenly spaced within each 
QTL to narrow the regions, and with additional data from 3 crossbred half-sib families, 
linkage to BRD was narrowed to one peak on chromosome 2 and two peaks on 
chromosome 26. These same 13 markers were then tested for association with BVDV-PI 
in PI calves and their dams. On chromosome 26, four loci were associated with the PI 
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calves while three different loci were associated with PI in the dams. If these data are 
supported in future studies, they suggest that selection protocols for the calves or the 
dams may need to be considered independently. In contrast, on chromosome 2, four loci 
were associated with PI of both the calves and their dams. Selection for these regions 
could prove to be beneficial to improve resistance to BVDV, or could contain 
information on the mechanisms through which the virus and host interact. Additionally, 
two loci on chromosome 2 were associated only with the dams of PI calves. Overall, 
three loci were identified to be linked to BRD and were also associated with BVDV-PI in 
claves and their dams. With continued focused research into genetic susceptibility or 
resistance to BVDV, loci can be selected for to improve the welfare of cattle.  
 In a follow up study to Neibergs et al. (2011), Zanella et al. (2011) refined the 
identified loci associated with PI of BVDV and BRD by analyzing 142 SNPs on 
chromosome 2 and 173 SNPS on chromosome 26. Multiple model types were run over 
all SNPs on a chromosome to identify genetic associations and then haplotype analyses 
were performed to identify if a haplotype would provide greater information for an 
association than a single SNP (Butler et al., 2005; Barrett, 2009). A locus was defined by 
SNPs that were individually associated with BVDV-PI, and haplotypes were constructed 
of SNPs that were individually associated but had a stronger association when grouped 
together. On chromosome 2, 33 SNPs and 11 haplotypes were associated with the dams 
of PI calves, while 9 SNPs and 4 haplotypes were associated with the PI calves. All four 
of the PI calves haplotypes overlapped with those associated with the dams suggesting 
these regions are associated with BVDV-PI in both the dams and the calves. For 
chromosome 26, there were 18 SNPs and 8 haplotype loci to be associated with the dams 
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of PI calves. The dominant model shared 17 of these SNPs, the most out of any of the 
models, suggesting a dominant mechanism of gene action. BVDV-PI was associated with 
29 SNPs on chromosome 26, and 11 haplotypes were identified. Six of these haplotype 
loci overlapped with loci identified to be associated with the dams of PI calves while the 
other five loci were unique to the PI calves. Overall the loci identified in the previous 
study were refined from approximately 7.4Mb down to 93kb-2Mb in size. On 
chromosome 2 all of the haplotypes associated with the PI calves were also associated 
with the dams, but there were seven additional haplotypes associated with only the dams. 
On chromosome 26, six of the eight loci associated with dams were shared with the PI 
calves while only six of the eleven loci associated with the calves were shared with the 
dams. From these analyses there is evidence to hypothesize that there are common and 
unique methods involved in the fight against persistent infection between the dam and the 
calves. Perhaps with further investigation into these shared loci an opportunity for 
selection will assist in limiting the effects of BVDV-PI and additionally BRD. 
 A genome wide association study to determine if regions containing SNPs could 
be associated with PI of BVDV was conducted based on 777,000 SNP markers by Casas 
et al. (2015). Persistently infected calves were identified by an antigen capture ELISA 
test and within 48 hours a second sample was taken for retest to confirm the PI status; 
this time frame does draw into question the validity of the diagnosis of PI. DNA was 
pooled from 1,200 affected and 1,200 unaffected calves in order to capture the allele 
frequencies of the population; from the affected and unaffected groups a subset of 192 
from each, were genotyped for associated SNPs. One SNP on chromosome 14 had a 
strong association while fifteen other SNPs on chromosomes 1, 2, 6, 8, 10, 15, and 18 
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were identified to have moderate association with BVDV-PI. The SNP on chromosome 
14 resides within the Raly RNA binding protein-like gene which has been proposed to 
have a function in mRNA splicing and 3’ formation of pre-mRNA (Jiang et al., 1998). 
This gene is down regulated in human cells infected with the swine influenza virus and it 
is possible that BVDV may have a similar function but gene expression analyses will 
need to be conducted for further understanding of this SNP effect in cattle (Wu et al., 
2013). With three moderately associated SNPs located on chromosome 2, these may 
suggest support for the findings of Neibergs et al. (2011) and Zanella et al. (2011) but are 
not conclusive due to the difference in location of 20Mb between markers. One 
moderately associated SNP on chromosome 10 is in high linkage disequilibrium with a 
gene that was found to have an association with chronic kidney disease in humans. In 
chronic kidney disease, RNA viruses from the Flaviviridae family trigger the release of 
interferons in cells but once the virus enters the cytoplasm of the cell it stops the 
interferon antiviral mechanism. This association could be possibly provide insight into 
the interferon response differences between the cytopathic and non-cytopathic biotypes. 
However, from these few studies little significant knowledge has been gained as to the 
genetics of cattle associated with susceptibility or resistance to PI of BVDV. 
 
RNA-Seq 
 The transcriptome consists of the complete quantity of transcripts in a cell/tissue 
for the specific stage of development and physiological conditions at the time in which 
the cell/tissue was sampled. The goals of transcriptomic analyses are to capture all 
mRNA, determine the transcriptional structure of genes, splicing variations, and to 
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quantify the expression levels under varying conditions (Wang et al., 2009). Sequencing 
approaches to RNA, termed RNA-Seq, directly determines the cDNA sequence and has 
revolutionized how transcriptomes are analyzed. A population of RNA, total or selected, 
is converted to a library of cDNA fragments with adaptors attached to one or both end 
depending on single-end or pair-end sequencing methods. Reads can range in size from 
30-500bp depending on the high-throughput sequencing technology applied (Emrich et 
al., 2007; Holt and Jones, 2008; Marioni et al., 2008). Sequenced reads are then aligned 
to a reference genome, a reference transcriptome, or assembled de novo to produce a map 
outlining transcript structure and quantity. An advantage is that RNA-Seq is not limited 
to detecting transcripts that correspond to existing annotated genomic sequence which 
makes RNA-Seq an attractive method for non-model organisms (Vera et al., 2008). 
RNA-Seq has the unique ability to identify the precise boundaries of transcription to a 
single nucleotide base and how exons are connected. RNA-Seq can also identify 
sequence variations like SNPs in the transcribed regions so DNA sequencing may not be 
a necessary addition (Cloonan et al., 2008; Morin et al., 2008). RNA-Seq is limited only 
by the number of reads collected and can illustrate a large dynamic range of expression. 
For example, a greater than 9,000 fold change in expression was estimated in a study that 
analyzed 16 million aligned reads and fold change differences spanning five orders of 
magnitude were estimated from a study with 40 million reads (Mortazavi et al., 2008; 
Nagalakshmi et al., 2008). With this range for detection RNA-Seq out powers 
microarrays which lack sensitivity for high and low expressed transcripts. With 
quantitative PCR serving as a control, RNA-Seq has demonstrated that it quantifies 
transcripts with high accuracy. The results also demonstrate high levels of reproducibility 
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for both technical and biological replicates (Cloonan et al., 2008; Nagalakshmi et al., 
2008).  
 There are several challenges that accompany RNA-Seq that should be addressed. 
First, RNA must be fragmented into small pieces to be compatible with the majority of 
deep-sequencing technologies. There are two methods, RNA fragmentation and cDNA 
fragmentation, which can be utilized to address this requirement but each method comes 
with its own resulting bias. RNA fragmentation creates a small bias towards the transcript 
bodies and lowers the quantity of transcript ends (Mortazavi et al., 2008). On the other 
hand, cDNA fragmentation strongly biases towards the 3’ ends but can provide valuable 
information for location (Nagalakshmi et al., 2008). In addition, during amplification 
short reads could possibly reflect a true projection of abundance or could be PCR 
artifacts. Another consideration is to prepare strand specific libraries which have the 
advantage of revealing transcript orientation which is valuable for annotation, and now is 
considered to be a standard practice in library preparation (Cloonan et al., 2008; Dutrow 
et al., 2008; Lister et al., 2008; Wilhelm et al., 2008). For large and complex 
transcriptomes it is difficult to map reads that span splice junctions due to alternative 
splicing and trans-splicing, and mapping is complicated further by reads that can match 
multiple locations in the genome (Mortazavi et al., 2008; Wilhelm et al., 2008). To detect 
rare transcripts and variants considerable coverage and depth are needed which can 
increase the sequencing cost. Increased depth is required for adequate coverage of large 
and complex transcriptomes, but there is not a common method to calculate the needed 
coverage due to the unknown variation of isoforms and quantities of transcripts. 
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 Despite these challenges, RNA-Seq has provided great insight into 
transcriptomics. With its high dynamic range and resolution, RNA-Seq has identified 
numerous novel transcription regions, splicing isoforms, and mapped 5’ and 3’ 
boundaries for multiple genes across multiple species. RNA-Seq will provide a unique 
method to study the differences between diseased and healthy animals as well as 
differences between physiological states over time. 
 Bovine viral diarrhea virus is a not an emerging virus, but little is understood of 
the interactions between the host’s genetics and the virus. To improve animal production 
and welfare, further research is needed to identify relationships for susceptibility and 
resistance to persistent infection. Between selection for resistance and improving current 
methods of control, the possibilities of potential eradication grow exponentially. To fulfill 
the need of genetic knowledge, this research utilized RNA-Seq to identify the variation of 
gene expression of persistently infected cattle to discover loci and markers of association 
for future selection.  
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CHAPTER II: THESIS 
Introduction 
 Persistent Infection (PI) with Bovine Viral Diarrhea Virus (BVDV) is a major 
source of economic loss for the livestock industry (Loneragan et al., 2005; Hessman et 
al., 2009). Persistent infection occurs when a dam is exposed to the virus during 42 to 
125 days of gestation and the virus is passed to the fetus without an adaptive immune 
response, in other words the virus is recognized by the calf as “self” (McClurkin et al., 
1984; Brownlie et al., 1989). These PI calves serve as continuous sources of infection to 
others. The identification of differences in expression of gene networks and/or genetic 
markers associated with infection could assist in the development of novel strategies to 
prevent, control, or treat BVDV. The purpose of this study was to utilize RNA-
Sequencing (RNA-Seq) to identify gene networks uniquely expressed in BVDV-PI beef 
cattle to further the knowledge of how these animals coexist with the virus. This 
knowledge will provide the groundwork for developing selective breeding programs to 
minimize the effects of the virus. The information gained may also lead to an 
improvement of current vaccinations, and may provide insight into alternative treatments. 
By improving the understandings of persistent infection in bovine, the translational basics 
will help to improve the prevention, diagnosis, and treatment of chronic infections of 
familial viruses in humans.  
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Methods 
Animal Identification and Classification 
A Kansas feedlot was identified in which all incoming animals are tested for 
BVDV by an antigen capture ELISA and, if positive for the virus, they are penned 
separately to limit the spread of infection. The feedlot was visited in April 2014, when 
samples were collected from all cattle that tested positive for BVDV upon entry (n=132). 
These infected animals were retested three weeks later for PI status by a second antigen 
capture ELISA at the UNL Diagnostic Laboratory, utilizing an ear notch for 
immunohistochemistry confirmation. 30ml whole blood samples for RNA and DNA 
sequencing were also drawn at this time and split into Tempus tubes (Life Technologies) 
and EDTA tubes respectively.  
Viruses isolated from each individual were classified by strain and subtype using 
polymerase chain reaction (PCR) of the 5’ untranslated region (UTR). To confirm the 
genotypes of the BVDV-2 strains, whole-genome sequences of the viruses were 
generated as a comparison to the 5’ UTR sequence classifications which grouped all nine 
viruses under the BVDV-2a subtype (Workman et al., 2016).  
After BVDV-PI status was confirmed, the 132 animals were divided into 
subgroups by virus strain and subtype. Since breed compositions were unknown, 
individuals included in the transcriptome analysis were then selected so there would be 
an even distribution of phenotypic characteristics including coat color, presence or 
absence of horns, and ear size represented in each group (Appendix A).  
In addition to PI cattle, two comparison groups were utilized. One termed “high 
exposure” was comprised of individuals collected from the same pen as the PIs. These 
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animals initially tested positive for the virus upon feedlot entry, but when retested for 
BVDV-PI, were confirmed negative. The second comparison group represents 
uninfected, unexposed individuals from a closed herd at the USDA Meat Animal 
Research Center (USMARC; Clay Center, NE) that had no previous record of exposure 
to the virus (“unexposed”; Appendix A). Overall 45 individuals were included in the 
RNA-Seq analyses (10 BVDV-1a, 8 BVDV-1b, 8 BVDV-2, 9 high exposure, and 10 
unexposed; Appendix A). 
 
RNA-Seq Analyses 
Total RNA was isolated from whole blood collected in Applied Biosystems 
Tempus Blood RNA tubes for RNA-Seq using the Applied Biosystems Tempus Spin 
RNA Isolation Kit. RNA integrity and concentration was quantified with an Agilent 
BioAnalyzer (Agilent Technologies, Santa Clara, CA) using the Agilent RNA 6000 Nano 
Kit for total eukaryotic RNA (Appendix A). An Illumina TruSeq Stranded mRNA 
Library Prep Kit with was used to construct cDNA libraries; six libraries were created at 
one time with each batch containing individuals classified as PI, uninfected, and high 
exposure. These libraries were sequenced as 75 base pair (bp), paired-end reads with an 
average insert size of 300 bp on an Illumina NextSeq across four lanes at the USMARC. 
Read quality was assessed with FASTQC (Andrews, 2010), trimmed with Trim 
Galore! (Krueger, 2015), and reassessed for quality improvement with FASTQC 
(Appendix B). The sequence reads were then aligned to a ribosomal RNA (rRNA) and 
mitochondrial RNA (mRNA) containing GTF file with Tophat 2.1 (Kim et al., 2013); 
Appendix B). The remaining reads that failed to align to the rRNA and mRNA file were 
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then sorted, split back into fastq pair files, and aligned to the UMD3.1 bovine genome 
with the full GTF file for gene annotation (Appendix B). The resulting aligned read files 
were then merged into one file per individual and inputted into Salmon (Patro et al., 
2015) for transcript quantification (Appendix B).  
 
Differential Expression Analyses 
The number of reads quantified by Salmon were inputted into edgeR, a R package 
from Bioconductor, for differential expression (DE) analysis (Robinson et al., 2010; 
Appendix B). The transcript counts were filtered by removing those reads that had less 
than one count per million in sample size n where n was equal to the smallest number of 
individuals in a group. A multidimensional scaling (MDS) plot of the biological 
coefficient of variation (BCV) was generated to visualize the heterogeneity of the 
expression among and between the groups. In order to examine the differences on a 
transcript level, pair wise comparisons were tested using ANOVA in R. The comparisons 
were BVDV-1a versus BVDV-1b, BVDV-1 versus BVDV-2, BVDV-PIs versus high 
exposure, BVDV-PIs versus unexposed, and high exposure to unexposed. These 
comparisons had false discovery rate (FDR) values calculated at the transcript level to 
account for multiple testing. Significant differentially expressed transcripts were defined 
by having a FDR less than 0.05. A secondary threshold, log fold change (logFC), of 
greater than two or less than negative two was also implemented. 
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Outlier Detection 
 Animals acting as outliers within each group were identified by visually 
examining the MDS plots based upon BCV. To visualize outliers within each group more 
clearly, the BCV plots containing only animals within each group (BVDV-PI, high 
exposure, unexposed) were used. 
 To gain a different perspective on possible outlier detection the variable plotted 
was changed from BCV to logFC. Plots were examined when including all individuals, 
and after removing the unexposed and high exposure groups.  
 
Differential Expression - Outliers Removed 
 After removing the outlier libraries, the reduced data was rerun through the edgeR 
script for DE analysis. An example of one of the pair-wise comparisons run was with the 
transcript counts of the three BVDV-PI groups added together, divided by a factor of 
three and then subtracting the value for the high exposure group. As there were 21 
BVDV-PIs, a DE analysis was also run comparing the high exposure group (n=9) to nine 
BVDV-PIs, three from each virus classification, to address the issue of potential 
differences arising from the group size variation. These nine BVDV-PIs were selected 
from a close grouping on the logFC plot generated with only the BVDV-PIs and 
represented three animals, each, infected with BVDV-1a, BVDV-1b and BVDV-2 
strains. 
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Manual Transcript Normalization 
 After the identification of the DE transcripts from the comparison between 
BVDV-PIs (n=21) and high exposure groups, the individual transcript counts were 
examined for each library in order to detect any individuals that appeared to be driving 
the DE. Any individual with a transcript count greater than two standard deviations from 
the group mean was deemed a count outlier; the transcript count for these individuals was 
replaced with the average of their representative group (excluding the outlier individual). 
DE analyses were then conducted on the modified data set. 
 
Ingenuity Pathway Analysis 
 The comparison transcript data from the BVDV-PI versus the high exposure 
group were uploaded into Ingenuity Pathway Analysis (IPA, QIAGEN Redwood City, 
www.qiagen.com/ingenuity) with a false discovery rate (FDR) threshold of 0.05, and a 
logFC threshold of greater than two or less than negative two. 
 
Results 
Animal Identification and Classification 
From the suspected BVDV-PI individuals (n=132) at the feedlot, 113 were 
confirmed positive, 7 atypical, and 12 negative. The confirmed BVDV-PI individuals 
were further classified by strain subtype resulting in identification of BVDV-1b (n=94), 
BVDV-1a (n=10), and BVDV-2 (n=9). The BVDV-2 strains were identified as BVDV-2a 
(n=4), BVDV-2c (n=2), and some intermediate BVDV-2? (n=3; Workman et al., In 
Review). Persistently infected animals within each viral strain, BVDV-1a, BVDV-1b, 
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BVDV-2, were selected to form homogeneous groups based off of phenotypic 
characteristics and were used for RNA-Seq (n=45; Appendix A). 
 
RNA-Seq Analyses 
All extracted RNA for cDNA libraries had a RNA Integrity Number (RIN) > 8. 
Next-generation sequencing resulted in 2,615,639,318 total reads with an average of 
58,125,318/individual. The number of reads lost due to trimming and quality standards 
were 8,137,334 (0.3%). Of the total reads, 3,972,902 reads (0.15%) aligned to the rRNA 
and mRNA GTF and were excluded from further analyses. Out of the remaining 
2,603,529,082 reads, 86% aligned to the UMD3.1 bovine genome. 
 
Multidimensional Scaling Plots 
Plotting all samples together, the BVDV-PIs are admixed with the high exposure 
animals, but both groups are separated from the unexposed animals (Figure 1.0).  
 
Figure 1.0 MDS plot of the Biological Coefficient of Variation. Each animal’s location is 
represented by an “X” followed by the animals’ library number. The viral classification is 
denoted by color. 
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Differential Expression Analyses 
EdgeR analyses showed no transcripts with significant DE when comparing the 
two BVDV-1 strains (Table 1.0). These two groups, BVDV-1a and BVDV-1b, were then 
merged for the comparison of BVDV-1 and BVDV-2, which also resulted in no 
significantly DE transcripts. Moving forward, all of the BVDV-PIs were grouped 
together for all comparisons. There greatest number of DE transcripts was observed 
between the high exposure and unexposed groups. The lowest number of DE transcripts 
was observed between the BVDV-PIs and the high exposure group.  
 
 
Table 1.0 Differentially Expressed Transcripts. The differentially expressed transcripts 
are those that met the threshold limit for false discovery rate of <= 0.05. There were a 
total of 13,587 expressed transcripts considered after normalization. The BVDV-1 group 
contains all of the BVDV-1a and BVDV-1b animals. 
*
The BVDV-PI group contains all 
of the BVDV-1a, BVDV-1b, and BVDV-2 animals. 
+
The Non-PIs group consists of the 
high exposure animals as well as the unexposed animals. 
Comparison Differentially Expressed Transcripts 
BVDV-1a vs BVDV-1b 0 
BVDV-1 vs BVDV-2 0 
High Exposure vs Unexposed 4,158 
BVDV-PIs
*
 vs High Exposure 1,032 
BVDV-PIs
*
 vs Unexposed 6,271 
BVDV-PIs
*
 vs Non-PIs
+ 
3,987 
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Outlier Detection 
The MDS plot based upon BCV of all samples except the unexposed shows the 
high exposure group separating from the BVDV-PIs with no distinct outlier individuals 
(Figure 1.1). However when plotting only the BVDV-PIs, 6 individuals fit the BCV 
criteria of an outlier: libraries number 15, 23, 26, 42, 49, and 34 (Figure 1.2). When the 
variable plotted was changed to logFC, the unexposed group separated from the BVDV-
PIs and high exposure groups (Figure 1.3). Following the same process as plotting with 
BCV, the high exposure group separates from the BVDV-PIs with no clear outlying 
individuals (Figure 1.4A). The same individuals appeared to be outliers that were 
identified by the BCV plot with the exception of library 34 who shifted closer to the other 
BVDV-PIs (Figure 1.4B).  
 
 
Figure 1.1 MDS plot of the Biological Coefficient of Variation of BVDV-PIs and High 
Exposure groups. Each animal’s location is represented by an “X” followed by the 
animals’ library number. The viral classification is denoted by color. 
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Figure 1.2 MDS plot of the Biological Coefficient of Variation of BVDV-PIs 
only. Each animal’s location is represented by an “X” followed by the animals’ library 
number. The viral classification is denoted by color. Visual outliers are circled. 
 
 
Figure 1.3 MDS plot of the Log Fold Change. Each animal’s location is represented by 
an “X” followed by the animals’ library number. Viral classification is denoted by color.  
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Figure 1.4 MDS plots of the Log Fold Change for A) BVDV-PIs and High Exposures, 
and B) BVDV-PIs only. Each animal’s location is represented by an “X”, followed by the 
animals’ library number and the viral classification is denoted by color. Outliers, 
removed from differential expression analyses, are circled.  
 
Differential Expression - Outliers Removed 
With a lower normalization threshold due to the removal of the outliers, there 
were a total of 13,476 transcripts analyzed for differential expression with 539 transcripts 
passing the FDR threshold of 0.05. From these 539 transcripts, 51 surpassed the logFC 
threshold. The nine by nine comparison resulted in 12,805 transcripts for analysis with 
354 DE transcripts and 28 transcripts over the logFC threshold. 
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Ingenuity Pathway Analysis 
 The most significant conical pathway across all three comparisons, BVDV-PIs 
versus high exposure, with outliers removed, and after manual transcript normalization, 
was the interferon signaling pathway (Appendix A). The genes identified in this pathway 
included ISG15 and OAS1 which were both upregulated in the BVDV-PIs. Included in 
the analysis results were significant networks with known biological associations 
(Appendix A). Networks associated with antimicrobial and inflammatory responses were 
commonly found across the three BVDV-PIs versus high exposure comparisons.  
 
Manual Transcript Normalization 
 Manual transcript normalization of the data resulted in seven fewer transcripts 
meeting the thresholds set for analysis in edgeR. With 13,469 transcripts available, there 
were 527 DE transcripts, slightly fewer than before manual normalization. Of these, 35 
transcripts passed the logFC threshold. All 35 of these transcripts previously passed all 
thresholds without manual count normalization. 
 
Table 1.1 BVDV-PIs versus High Exposure Differentially Expressed Transcripts. 
Differentially expressed transcripts that met the false discovery rate and log fold change 
thresholds and were uploaded into IPA. Those with no associated name are identified as 
novel transcripts. The asterisk represents the associated gene names of an orthologous 
transcript annotated in another species. The plus symbol represents transcripts with 
known orthologs identified for pathway analysis. 
Ensembl Transcript ID logFC FDR Associated Gene Name 
ENSBTAT00000009798+ 2.15 7.05E-06 C2 
ENSBTAT00000004093 3.97 6.46E-05 IFI27* 
ENSBTAT00000019477+ 3.21 6.34E-06 OAS2 
ENSBTAT00000011146+ 2.33 5.40E-05 MX2 
ENSBTAT00000066038 2.74 5.40E-05 BST2* 
ENSBTAT00000026613+ 2.46 5.22E-06 CMPK2 
ENSBTAT00000061135+ 2.43 5.22E-06 PLEKHA4 
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ENSBTAT00000028036+ 3.42 3.25E-05 ADM 
ENSBTAT00000021373+ 3.15 2.76E-05 RSAD2 
ENSBTAT00000022896 2.49 2.14E-06  
ENSBTAT00000001496 -3.37 2.09E-05 ADAMDEC1 
ENSBTAT00000044986 2.25 1.96E-06 OAS1X 
ENSBTAT00000043762+ 2.79 1.95E-06 FAM3B 
ENSBTAT00000048651+ 2.60 1.52E-06 IFI44 
ENSBTAT00000016856+ 3.10 1.52E-06 OAS1* 
ENSBTAT00000018757+ 3.40 1.52E-06 CCL8 
ENSBTAT00000017523+ 2.93 1.50E-05 SIGLEC1 
ENSBTAT00000015014 2.19 1.02E-05 C1R 
ENSBTAT00000015085+ -6.44 0.032732 TMEM259 
ENSBTAT00000061306+ -2.71 0.027881 MYH7 
ENSBTAT00000057360 -4.02 0.018796 RRAGA* 
ENSBTAT00000020716+ 2.45 0.012204 SLCO2B1 
ENSBTAT00000045436 2.04 0.011622 C2 
ENSBTAT00000045468 2.43 0.009831 C4A/B* 
ENSBTAT00000045694+ -2.28 0.007061 HBD/B 
ENSBTAT00000004444 2.97 0.003284 IFI27* 
ENSBTAT00000010659+ -3.44 0.002557 CRTAC1 
ENSBTAT00000046532 -3.03 0.00217  
ENSBTAT00000037545 -2.86 0.001785 HBA1/2* 
ENSBTAT00000022034 -2.86 0.001785 HBA1/2* 
ENSBTAT00000015237+ 2.07 0.000582 BATF2 
ENSBTAT00000017547+ 2.83 0.00045 TIMD4 
ENSBTAT00000002019 2.56 0.00024 OAS1X 
ENSBTAT00000019573+ 2.77 0.000161 ISG15 
ENSBTAT00000051987 -3.54 0.000154 PNP* 
 
Table 1.2 BVDV-PIs versus Unexposed Differentially Expressed Transcripts. 
Differentially expressed transcripts that met the false discovery rate and log fold change 
thresholds and were uploaded into IPA. Those with no annotated name in UMD3.1 are 
identified as novel transcripts. The asterisk represents associated gene names of an 
orthologous transcrpit. 
Ensembl Transcript ID LogFC FDR Associated Gene Name 
ENSBTAT00000064245 -2.14 1.04E-12  
ENSBTAT00000039338 -2.02 2.35E-12 SLC4A11 
ENSBTAT00000011679 -2.18 7.06E-12 GPC2 
ENSBTAT00000012158 -2.53 9.35E-12 SCUBE3 
ENSBTAT00000023278 -2.03 1.28E-11 CCDC168* 
ENSBTAT00000020444 -2.76 2.37E-11 SLC16A4 
ENSBTAT00000064024 -2.19 3.67E-11  
ENSBTAT00000033832 -2.49 8.90E-11 RAPGEF5 
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ENSBTAT00000027771 -2.26 1.98E-10 MEGF6 
ENSBTAT00000006265 -2.27 6.41E-10 SCN4A 
ENSBTAT00000065643 -2.34 8.76E-10 SYT2 
ENSBTAT00000057593 2.24 2.58E-09 ELN 
ENSBTAT00000063826 -3.55 4.07E-09 UTY 
ENSBTAT00000052450 -2.28 1.09E-08 ATAD2 
ENSBTAT00000010544 2.05 1.10E-08 BST2* 
ENSBTAT00000055354 -2.75 1.32E-08 HTR3E 
ENSBTAT00000065355 -2.75 1.94E-08 CDC14A 
ENSBTAT00000046675 -2.42 3.05E-08  
ENSBTAT00000063652 -2.28 5.98E-08  
ENSBTAT00000015631 -2.01 9.09E-08 PPP1R12B 
ENSBTAT00000044746 -2.08 1.67E-07 GLTSCR1 
ENSBTAT00000055272 -2.47 1.84E-07 ADAM28 
ENSBTAT00000022254 -2.00 2.38E-07 RASAL1 
ENSBTAT00000014364 2.29 4.37E-07 GZMH* 
ENSBTAT00000004093 3.41 1.14E-06 IFI27* 
ENSBTAT00000034686 -2.07 1.38E-06 KCNJ16 
ENSBTAT00000064489 -2.18 2.18E-06 C11ORF95 
ENSBTAT00000050251 -2.22 2.92E-06 NINL* 
ENSBTAT00000009441 2.94 3.30E-06 PDGFRA 
ENSBTAT00000015593 -2.18 3.58E-06 TLL2 
ENSBTAT00000024391 3.73 5.31E-06 CLEC3B 
ENSBTAT00000050712 -2.56 6.81E-06 NINL* 
ENSBTAT00000020194 2.29 7.67E-06 PRSS23 
ENSBTAT00000001496 -2.55 1.09E-05 ADAMDEC1 
ENSBTAT00000017363 2.26 1.11E-05  
ENSBTAT00000030760 3.98 1.49E-05 FRMD4B 
ENSBTAT00000000339 2.35 1.71E-05 IL5RA 
ENSBTAT00000065429 -3.80 2.91E-05 GTPBP1 
ENSBTAT00000026930 -2.01 3.11E-05 WNT5A 
ENSBTAT00000024381 -4.15 3.22E-05 PAOX 
ENSBTAT00000035191 5.79 3.53E-05 ABR 
ENSBTAT00000006557 -2.02 6.74E-05 GPLD1 
ENSBTAT00000016414 3.71 8.99E-05  
ENSBTAT00000006358 3.30 0.000101 C1S 
ENSBTAT00000004562 4.71 0.000115 DCN 
ENSBTAT00000057500 2.57 0.000116 HSPA6 
ENSBTAT00000037768 2.98 0.000169 EIF4G3 
ENSBTAT00000033863 4.86 0.000179 COL3A1 
ENSBTAT00000006512 -2.35 0.000228 FAM84A 
ENSBTAT00000018130 2.41 0.000231 KLRG1 
ENSBTAT00000017420 4.81 0.000248 COL1A1 
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ENSBTAT00000009467 -2.15 0.000251 SIDT2 
ENSBTAT00000014055 2.46 0.0005 PRG3* 
ENSBTAT00000004627 2.18 0.000536 THADA 
ENSBTAT00000028617 4.70 0.000553 COL3A1 
ENSBTAT00000020716 2.43 0.000924 SLCO2B1 
ENSBTAT00000064073 6.40 0.000954 NCL* 
ENSBTAT00000004444 2.06 0.000983 IFI27* 
ENSBTAT00000050266 2.05 0.003079  
ENSBTAT00000029208 3.81 0.003514 ACTA2 
ENSBTAT00000015085 -3.88 0.003586 TMEM259 
ENSBTAT00000007924 2.57 0.005116 LYZ* 
ENSBTAT00000063354 -2.58 0.012218 ANO8 
ENSBTAT00000015668 2.20 0.014185 COL6A1 
ENSBTAT00000025663 2.14 0.015743 CLEC3B 
ENSBTAT00000066019 2.39 0.015787 TRAV8* 
ENSBTAT00000019758 2.21 0.016151 SPARC 
ENSBTAT00000064533 2.12 0.019613  
ENSBTAT00000046279 2.02 0.047571 HLA-DQB1/2* 
 
Table 1.3 High Exposure versus Unexposed Differentially Expressed Transcripts. 
Differentially expressed transcripts that met the false discovery rate and log fold change 
thresholds and were uploaded into IPA. Those with no annotated name are identified as 
novel transcripts. The asterisk represents associated gene names of an orthologous 
transcript. 
Ensembl Transcript ID LogFC FDR Associated Gene Name 
ENSBTAT00000023278 -2.04 3.55E-09 CCDC168* 
ENSBTAT00000020444 -2.81 6.26E-08 SLC16A4 
ENSBTAT00000064245 -2.45 6.39E-08  
ENSBTAT00000063652 -3.33 7.49E-08  
ENSBTAT00000022896 -3.75 8.78E-08  
ENSBTAT00000018496 -2.76 1.66E-07 HERC2 
ENSBTAT00000024084 -2.11 1.69E-07 KMT2A 
ENSBTAT00000065429 -10.09 1.79E-07 GTPBP1 
ENSBTAT00000017847 -2.51 2.16E-07 NFAT5 
ENSBTAT00000020277 -2.49 2.62E-07 UBR4 
ENSBTAT00000018746 -2.01 2.74E-07 MBNL3 
ENSBTAT00000011679 -2.12 3.34E-07 GPC2 
ENSBTAT00000052450 -3.06 7.53E-07 ATAD2 
ENSBTAT00000035354 -2.34 1.09E-06 SLFN12* 
ENSBTAT00000005261 -2.30 1.40E-06 LCOR* 
ENSBTAT00000038286 -2.22 1.72E-06 INO80D 
ENSBTAT00000035191 6.88 2.12E-06 ABR 
ENSBTAT00000033863 3.79 2.29E-06 COL1A2 
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ENSBTAT00000017420 3.75 2.35E-06 COL1A1 
ENSBTAT00000065285 -2.17 2.83E-06 NBEAL1 
ENSBTAT00000014551 -2.12 3.01E-06 HECTD4* 
ENSBTAT00000010591 -2.04 3.15E-06 GCFC2 
ENSBTAT00000006265 -2.23 4.06E-06 SCN4A 
ENSBTAT00000019193 -2.66 4.08E-06 KMT2D 
ENSBTAT00000055354 -3.35 4.60E-06 HTR3E 
ENSBTAT00000030444 -2.08 5.92E-06 RNF213 
ENSBTAT00000057049 -2.07 5.92E-06  
ENSBTAT00000064969 -2.30 7.17E-06 OTUD3 
ENSBTAT00000064608 -2.64 8.38E-06 GOLGB1 
ENSBTAT00000065887 -2.03 8.81E-06 ZNF24 
ENSBTAT00000044746 -2.49 9.83E-06 GLTSCR1 
ENSBTAT00000035892 -2.21 1.12E-05 DMXL2 
ENSBTAT00000000339 3.35 1.84E-05 IL5RA 
ENSBTAT00000038788 2.35 2.33E-05 SV2B 
ENSBTAT00000014364 2.31 2.39E-05 GZMH* 
ENSBTAT00000019477 -2.86 3.25E-05 OAS2 
ENSBTAT00000065355 -2.71 3.56E-05 CDC14A 
ENSBTAT00000007811 2.44 3.67E-05 CEBPE 
ENSBTAT00000027080 3.15 4.32E-05 ALOX5 
ENSBTAT00000014055 2.58 5.54E-05 PRG3* 
ENSBTAT00000027024 2.05 6.53E-05 HPGD 
ENSBTAT00000014612 -2.31 7.75E-05 CCDC136 
ENSBTAT00000065082 -2.16 7.76E-05 OTUD3 
ENSBTAT00000001810 2.24 9.59E-05 CLDN3 
ENSBTAT00000065956 -2.01 0.000114 PIK3R5 
ENSBTAT00000042717 2.28 0.000121 VCAN 
ENSBTAT00000017363 2.27 0.000126  
ENSBTAT00000050251 -3.17 0.000129 NINL* 
ENSBTAT00000031648 2.34 0.000155  
ENSBTAT00000015631 -2.04 0.000164 PPP1R12B 
ENSBTAT00000063826 -3.55 0.000177 UTY 
ENSBTAT00000015911 2.13 0.000233 ALOX15 
ENSBTAT00000016989 2.34 0.000382 MPO 
ENSBTAT00000050712 -2.28 0.000383 NINL* 
ENSBTAT00000012835 2.07 0.000441 FBP1 
ENSBTAT00000064234 3.58 0.000469 PIK3CB 
ENSBTAT00000030760 3.53 0.000487 FRMD4B 
ENSBTAT00000066254 2.44 0.000602  
ENSBTAT00000054450 2.95 0.000768 HBM 
ENSBTAT00000038558 2.41 0.000808 ASB2 
ENSBTAT00000009467 -3.21 0.000879 SIDT2 
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ENSBTAT00000037768 2.98 0.001567 EIF4G3 
ENSBTAT00000011308 -2.54 0.003188 ZFP36 
ENSBTAT00000006337 2.41 0.003217 REEP1 
ENSBTAT00000024381 -3.64 0.003461 PAOX 
ENSBTAT00000045694 2.94 0.00358 HBB 
ENSBTAT00000006557 -2.34 0.003901 GPLD1 
ENSBTAT00000017538 2.27 0.004256 ALAS2 
ENSBTAT00000066115 2.37 0.004586 SRBD1 
ENSBTAT00000065187 -2.59 0.007424 CREBRF 
ENSBTAT00000048965 2.14 0.012314 MLH1 
ENSBTAT00000064533 2.60 0.016715  
ENSBTAT00000022034 2.60 0.019347 HBA1/2* 
ENSBTAT00000037545 2.60 0.019347 HBA1/2* 
 
Discussion 
Identification of Samples 
 The retesting of putative BVDV-PI cattle three weeks after their arrival at the 
feedlot proved to be a valuable exercise in the conformation of PI status as not all animals 
were conclusively PI. These results provided the unique opportunity for the inclusion of 
the high exposure group of animals for comparison to the BVDV-PIs. The high exposure 
animals were penned with the BVDV-PI individuals due to their initial positive test for 
the presence of the virus, and were most likely experiencing an acute infection at time of 
arrival. Due to the three week difference in retesting the high exposure animals most 
likely had residual expression from an acute infection. The atypical status from PI 
confirmation testing was derived from the immunohistochemistry results not clearly 
being confirmed or denied. All individuals included were selected based on phenotypic 
characteristics to balance and neutralize the possible effects of identification of 
phenotypic specific expressional differences. 
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Viral Classification 
 While 5’ UTR amplification has been the standard method for BVDV strain and 
subtype classification, there is 70% sequence similarity in this region between BVDV-1 
and BVDV-2. In order to confidently classify the viral strains, whole genome sequence 
data of the BVDV-2 strains were produced for comparison resulting in subdivisions. The 
conventional 5’UTR method classified all nine BVDV-2 viruses as BVDV-2a while the 
whole genome sequence data confirmed the presence of BVDV-2c and BVDV-2 of 
unidentified strains (Workman et al., 2016). This information is valuable since BVDV-2a 
is considered to be the predominate strain of BVDV-2 in the United States (Fulton et al., 
2005). These data suggest that the commonly used method of classification (5’ UTR) 
may not be accurately capturing the diversity of the pathogen in the US. These also allow 
for better monitoring of shifting viral demographics, which is important to consider when 
implementing control strategies. Despite the newly discovered variety among BVDV-2 
strains, due to the limited numbers of the subtypes, all nine BVDV-2 individuals were 
grouped together for the analyses. 
 
Differential Expression Analyses 
Salmon was selected for transcript quantification due to the robustness of the 
quasi-mapping method it utilizes. Instead of base to base alignment, quasi-mapping uses 
a k-mer length that acts as a minimum acceptable length of sequence for a valid match to 
a known transcript. This alignment method allows for sequence variation as well as 
differential splicing to be have a greater chance of being properly assigned and 
quantified. 
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The arrangement of the animals in the inclusive BCV MDS plot suggests that the 
animals are not separating by phenotypic characteristics or breed specific genetics and 
supports the selection effort to neutralize these differences between groups (Figure 1.0). 
Instead, the expression patterns of the BVDV-PIs are more similar to the high exposure 
animals while greatly differing from the unexposed animals. With the least amount of DE 
transcripts between the high exposure group and the BVDV-PIs and the most difference 
between the BVDV-PIs and the unexposed, uninfected group, the ANOVA comparisons 
support the BCV plot (Table 1.0). The large difference between the BVDV-PIs and the 
unexposed group could be due to the difference in timing and geographic location of 
when the RNA sampling occurred; samples were drawn April, 2014, for the BVDV-PIs 
and May, 2015, for the unexposed animals. Due to the concern that the DE between the 
unexposed group and others may be driven by factors other than infection status, the 
unexposed group was removed from the main analyses. At the same time, the limited 
difference between the BVDV-PIs and the high exposure group could imply a common 
innate immune response to BVDV. 
 There were no transcripts that were significantly DE between the BVDV-1a and 
the BVDV-1b subtypes, as well as between the BVDV-1 and BVDV-2 strains. This result 
was unexpected due to previous research which has demonstrated expression differences 
in response to different strains, different subtypes, and even viruses of the same strain and 
subtype (Gibson et al., 2011; Rajput et al., 2014). On the other hand, these experiments 
are conducted in vitro with single bovine cell lines and types while our data resulted from 
whole blood drawn from naturally infected PI cattle. The differences among the studies 
may also be due to acute nature of the in vitro studied infection versus our study of 
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persistent infection which results in observable physiological response differences. The 
response difference to the strains and subtypes may be different when there is a persistent 
infection that is established at an early time in the development of the immune system; 
transient infections occur after the immune system is fully developed and have the 
potential to be exposed to plural pathogens. 
 
Outlier Removal 
When identifying probable outliers, six samples clearly clustered apart from the 
others when plotting both the BCV and logFC variables. Library number 34 was 
positioned between the outliers and the rest of the PIs (Figure 1.2). In the logFC plots 
Library 34’s location shifted closer to the PIs and further away from the other 5 
individuals and thus was ultimately not included as an outlier (Figure 1.5). Removal of 
these outliers was performed in order to make sure the groups were homogeneous 
representatives of their physiological states. If one individual is drastically different in 
expression patterns from the rest of the group then when the group as a whole is 
considered it is not a true representation of the current physiological state.  
 
Manual Transcript Normalization 
 Differential gene expression can be swayed by wide variation within each 
group resulting in false positives or negatives. In order to identify any possible outlier 
transcript counts, which may be due to PCR bias, any count outside of two standard 
deviations from the mean of the was replaced with the group mean excluding the outlier. 
Several DE transcripts were affected by this process. Of the 51 transcripts that were DE 
50 
 
and passed the logFC threshold after removal of the outlier individuals, 35 of these 
transcripts remained meeting the criteria for significant DE after manual normalization. 
From the 16 transcripts that did not remain significant, 4 were DE (FDR < 0.05) but did 
not meet the logFC threshold; the other 12 were no longer significantly DE as defined by 
FDR. Due to these results we believe that we were able to reduce our within group 
variation while retaining the integrity of our data. An example of one transcript that was 
influenced by a single extreme count was ENSBTAT00000010295 (Appendix A). This 
transcript, belonging to the gene TG (thyroglobulin), was the top DE transcript with a 
logFC of -8.145. Upon inspection of the raw counts, it was observed that 214,064 reads 
of this transcript were observed in one individual (library 40), while the mean of the 
others in the group was 142.5 (range 58 to 262). After normalization of only that 
individual, the transcript is no longer DE. In these instances, the individuals themselves 
were not outliers, but the single transcript count was suspect.  
 
Ingenuity Pathway Analysis 
 When the data from the ANOVA comparison between all BVDV-PIs versus the 
high exposure group was uploaded into IPA, the top canonical pathways represented 
included interferon signaling, role of pattern recognition receptors in recognition of 
bacteria and viruses, and cardiomyocyte differentiation via bone morphogenetic protein 
receptors (Appendix A). These three canonical pathways remained present through the 
analyses even with the removal of the outliers and the manual transcript count 
normalization which suggests the results are indicating processes unique to BVDV-PIs 
and were not driven by the presence of these outliers. While the gene expression of the 
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BVDV-PIs suggests there is an up-regulation of the interferon signaling pathway, there 
are genes present in our data set that have known interactions with the virus. MX2 has 
been found to be regulated by BVDV due to the RNASE activity of the BVDV E
rns 
protein which attempts to degrade PAMPs (Peterhans and Schweizer, 2013); however, 
this gene’s increased expression in the BVDV-PIs as compared to the high exposure 
animals causes IPA to predict an increase in the interferon signaling pathway.  
 
 
Figure 1.5 Interferon Signaling Pathway of BVDV-PIs verse High Exposure. Genes 
highlighted in color are represented in our data set. Red shading indicates upregulation in 
the BVDV-PIs 
 
An upstream regulator of MX2 in the interferon pathway is IRF3 which is also 
known to be regulated by the virus at a protein level (Chen et al., 2007). Due to the 
increase of gene expression in the interferon pathway, it would be logical to conclude that 
the BVDV-PIs are mounting an interferon response. On the other hand, the BVDV-PIs do 
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not have a detectable interferon response due to the efforts of the virus. The observed 
gene expression data is possibly driven by an innate immune response to the virus which 
is halted at the protein level before it can progress any further.  
Networks related to the inflammatory response, antimicrobial response, and cell 
signaling are identified among all three BVDV-PI versus High Exposure comparisons. 
All three of these networks have roots with the innate immune response which can also 
have effects that tie into the identified network association of carbohydrate metabolism. 
The continuous innate response since the birth of the animal could possibly explain why 
there are many networks being identified with associations to development.  
Based upon prior data, BVDV-PIs should not be having an innate immune 
response since the virus is introduced during the development of the immune system. Due 
to this early timeframe, BVDV-PIs are not able to produce antibodies against the virus 
and are considered to be immunotolerant. Tolerance is classified into central tolerance or 
peripheral tolerance and both relate to antibodies. Central tolerance refers to the deletion 
of autoreactive lymphocytes before they fully develop. This process is done in order to 
preserve the response to antigens while protecting the host’s tissues. Peripheral tolerance 
occurs after T and B cells mature to prevent lymphocytes from initiating a too strong of a 
response which could potentially be dangerous. From the breaking down of the 
definitions of the components of immunotolerance, they suggest that this tolerance takes 
place specifically at the acute phase response of the immune system while leaving the 
innate response fully intact. Our data support this possible conclusion in that BVDV-PIs 
do not produce antibodies against the virus but their gene expression patterns suggest 
there might be an active innate response. 
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Over all, the continuous stress the virus places on the animals’ system as it 
develops could be the driving force behind the phenotype of the BVDV-PIs. With a 
constant active innate immune response, the animal is forced to alter their normal gene 
expression in order to adapt to survive. By studying BVDV-PI gene expression patterns it 
is clear that these animals welfare is compromised at a molecular level. Though our 
BVDV-PIs were not tested for secondary infection, it could be possible that the 
expression patterns observed were from a different pathogen or the combination thereof.  
 
Associated Loci 
Prior studies with BVDV have attempted to identify loci associated with PI and 
acute infection in calves and their dams. In the studies conducted by Neibergs et al. 
(2011) and Zanella et al. (2011), there was identification of loci associated with BVDV-
PI on BTA2 and BTA26. In contrast, there were no transcripts identified in our data that 
were derived from BTA2 and there was only one transcript, ENSBTAT00000010659, 
from BTA26. This transcripts associated gene is CRTAC1, but its location is 14Mb away 
from the nearest marker used in both prior studies and unlikely driving the signal 
observed by Neibergs et al. (2011). In the study conducted by Casas et al. (2015), there 
was a genome wide association study conducted which identified several single 
nucleotide polymorphisms (SNP) across the genome which may be associated with the 
incidence of BVDV-PI. Casas et al. (2015) identified associated SNPs on 1, 6, 8, 10, 15, 
and 18, however, all SNPs were minimally 7Mb away from any of our DE transcripts. At 
these distances it is unlikely that these results are correlated. While these distances do not 
suggest support for their findings, there may be interactions at a protein level or common 
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regulatory factors that possibly explain the differences in location while providing 
possible support for associated loci. 
 
Expression Studies 
 Previous studies examining cattle’s gene expression response to BVDV have 
identified patterns of interest. In a study conducted by Müller-Doblies et al. (2002), the 
authors examined the in vitro response of the MX1 gene to various viruses including 
BVDV. The MX1 gene has known antiviral response activities to many viruses that are 
induced by type I and II interferons. MX1 was upregulated in response to BVDV, but in 
our data MX1 was not significantly DE while MX2 was upregulated. Though, when our 
transcript data were uploaded into IPA the bovine MX2 transcript was identified as the 
human ortholog MX1 (Figure 1.5). If the bovine MX2 gene has the same antiviral activity 
as the human MX1 gene, then the upregulation of MX2 in BVDV-PIs would follow our 
hypothesis that they are mounting an innate response. 
 An in vivo study conducted by Palomares et al. (2013) identified several 
interferon related genes that were upregulated in acutely infected cattle. IFN-α and IFN-β 
were upregulated in cattle which were infected with a high virulence BVDV-2 strain but 
not in cattle infected with a low virulence BVDV-1a strain when compared to a group of 
uninfected cattle. MX1, PKR, OAS-1, and ISG15 were all upregulated in both the BVDV-
2 and BVDV-1a infected cattle, but OAS-1 and ISG15 had significantly greater 
expression in the BVDV-1a cattle than the BVDV-2 cattle. IFN-α and IFN-β were not 
significantly DE in our data, and this may be due to the persistent infection status in 
which the virus continuously tries to block the interferon response. MX1 and PKR were 
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not significantly DE in our data either, but this may be due to the RNase activity of the 
viral protein Erns which degrades any dsRNA that can activate these two genes. OAS-1 
and ISG15were significantly DE with a logFC greater than two in our data which 
correlates with the increased expression they detected. While we did not see a significant 
difference in expression between the strains in our analyses, this may be due to the 
different type of infection, acute versus persistent.  
 Shoemaker et al. (2009) detected increased expression of interferon related genes 
in an in vivo and natural persistent infection study. In their study, MX2, PKR, OAS-1, 
ISG15, RIG-I, MDA5, LGP2 and IFI44 had increased expression with a fold change 
greater than 1.5 in the PI cattle when compared to the uninfected cattle. MX2, OAS-1, 
ISG15, and IFI44 were all significantly DE with the same logFC directionality in our data 
which correlates with their results. Meanwhile RIG-I, MDA5, LGP2, and PKR were not 
significantly DE in our data. RIG-I and MDA5are both innate immune receptors that 
recognize dsRNA and viral nucleic acids respectively, but these were not significantly 
DE in our data. LGP2 is a regulator of both RIG-I and MDA5, and is known to have 
positive and negative effects on the interferon response. The reason why we might not 
have seen these genes DE could be due to the effects of the Erns protein. 
 With previous studies that have identified the same genes with the same 
directionality of DE, these correlating results serve to increase the confidence in our own 
results. From the genes mentioned above it appears that the interferon pathway plays a 
crucial role in persistent infection and future studies will be needed to identify the 
components which allow for increased susceptibility or resistance to BVDV. 
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Translational Expression 
 Bovine viral diarrhea virus persistent infection may be comparable to how chronic 
hepatitis c infections (HCV) are able to be established. Due to the familial classification 
of these two viruses and that they are both able to survive in their host’s systems for 
extended periods of time, some of the knowledge gained from studying one might be 
applicable to the other. The top two canonical pathways, interferon signaling and role of 
pattern recognition receptors in recognition of bacteria and viruses, are influenced by the 
expression of ISG15, OAS1, and OAS2. ISG15 had an expression logFC increase of 2.77 
in the BVDV-PIs as compared to the high exposure animals while OAS2 had an increase 
of 3.2 and OAS1 was increased by 3.1. In a study conducted by (Chen et al., 2010) there 
were data suggesting that HCV exploits ISG15 to increase HCV replication. They found 
over expression of ISG15 to increase HCV RNA three fold, and blocking production of 
ISG15 largely decreased the replication of the virus. Due to the increased expression of 
ISG15 in the BVDV-PIs, these results may be correlated in that a similar chronic 
infection of a familial virus may have the same effect. In studies conducted by (Zhao et 
al., 2013; Barkhash et al., 2014), polymorphisms in genes OAS1 and OAS2 were 
associated with susceptibility and predisposition to chronic hepatitis c infections. While 
our expression data does not extend to polymorphism identification, there is greater 
expression of these two genes in BVDV-PIs; additional assays would be required to 
identify the effect of a polymorphism if one were present. Chronic hepatitis c has been a 
more widely studied virus when examining the host’s gene expression response and with 
the correlations that can be drawn from similar expression patterns in BVDV-PIs; the 
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vast knowledge in human research may assist in furthering our understanding of 
persistent infection. 
 
Conclusions and Future Directions 
From this experiment, the expression pattern of BVDV-PIs more closely mirrors 
that of the high exposure animals as compared to the unexposed animals. While 
surprising due to the immunotolerant status of PIs, this knowledge has shed light on 
novel interactions between the host and the virus. Not being able to produce antibodies 
against the source of PI, BVDV-PI animal’s gene expressions suggest they are attempting 
to mount an innate immune response to the virus. Moving forward more research will 
need to be done to examine regulatory factors that may have a widespread influence over 
multiple genes, and identification of protein interactions with the virus will help explain 
the differences observed between expression and actualization of the immune system. 
While there was identification of gene networks possibly unique to BVDV-PIs, which 
may influence susceptibility, there will need to be further studies conducted to narrow the 
scope before this information can be utilized in a selective breeding program. 
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APPENDIX A 
1.0 Table of cDNA Libraries 
Animal ID Library ID Classification RIN RNA Concentrations (ng/uL) 
11 28 1a 10 112 
27 26 1a 9.2 212 
29 41 1a 9.3 102 
51 17 1a 8.9 193 
57 44 1a 9.2 122 
77 38 1a 8.8 512 
88 22 1a 8.7 192 
91 34 1a 9.2 275 
96 11 1a 9.3 186 
127 50 1a 9.4 231 
6 24 1b 10 149 
12 29 1b 10 337 
39 43 1b 8.7 122 
40 15 1b 8.5 182 
46 9 1b 8.1 74 
70 49 1b 9.1 42 
72 4 1b 8.9 200 
107 42 1b 9.3 169 
15 31 2 9.8 135 
37 14 2 9.3 110 
61 48 2 9.1 135 
65 10 2 9.4 89 
76 37 2 9.2 160 
83 27 2 9.0 230 
92 6 2 8.2 131 
106 23 2 8.3 384 
20143009 8 Unexposed 9.5 245 
20143102 20 Unexposed 9.9 476 
20143112 35 Unexposed 10 336 
20143140 7 Unexposed 10 488 
20143164 39 Unexposed 9.4 239 
20143234 25 Unexposed 9.6 392 
20143410 32 Unexposed 10 378 
20143442 16 Unexposed 10 579 
20143510 46 Unexposed 10 402 
20143742 12 Unexposed 9.6 371 
3 30 High Exposure 9.2 129 
14 40 High Exposure 9.0 113 
24 13 High Exposure 8.9 118 
26 47 High Exposure 8.4 83 
50 33 High Exposure 8.9 122 
53 36 High Exposure 8.9 121 
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60 21 High Exposure 9.1 118 
82 5 High Exposure 8.7 150 
124 45 High Exposure 9.4 235 
 
 
1.1 Table of Phenotypic Data of Persistently Infected and High Exposure Animals 
Animal ID 
Viral 
Classification 
Large 
Ears 
Horn 
Status 
Body Color Head Color 
11 1a No Horned Red and White White 
27 1a No Polled Black Black 
29 1a No Polled Black Black 
51 1a Yes Polled Black Black 
57 1a Yes Polled Black Black 
77 1a No Polled Cream Cream 
88 1a No Polled Black Black 
91 1a Yes Polled Red Red 
96 1a No Polled White and Grey White and Grey 
127 1a No Polled Black and White Black 
6 1b No Polled Black Black and White 
12 1b No Polled Grey and White Grey and White 
39 1b Yes Polled Black and White Black 
40 1b No Polled Black Black 
46 1b Yes Polled Black Black 
70 1b Yes Polled Red Red 
72 1b No Polled Black Black 
107 1b No Polled Red White 
15 2 No Polled Brown and White Brown and White 
37 2 Yes Horned Black and White Black 
61 2 Yes Polled Black Black 
65 2 No Polled Red and White Red 
76 2 No Polled Black Black and Red 
83 2 Yes Horned Red and White Red and White 
92 2 No Polled Black Black 
106 2 Yes Horned Tan Tan 
3 High Exposure Yes Polled Red and Brown Red and Brown 
14 High Exposure No Polled White White 
24 High Exposure No Polled Black Black 
26 High Exposure Yes Polled Brown and Grey Brown and Grey 
50 High Exposure No Polled Red Red and White 
53 High Exposure No Polled Black Black 
60 High Exposure No Horned Grey Brown White 
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82 High Exposure Yes Polled Red Red 
124 High Exposure No Polled Red and White Red and White 
 
 
1.2 Table of Phenotypic Data of Unexposed, Uninfected USMARC Animals 
Animal ID Sire Line 
Maternal Grand 
Sire Line 
Color Sex 
20143112 Charolais Charolais White M 
20143140 Santa Gertrudis Santa Gertrudis Red M 
20143234 Brangus Brangus Black M 
20143510 Simmental Simmental Red M 
20143442 Hereford Hereford Red and White M 
20143410 Angus Angus Black M 
20143102 Simmental Simmental Black and White F 
20143164 Hereford Hereford Red and White F 
20143009 Angus Angus Black F 
20143742 Charolais Charolais White F 
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1.3 Table of Ingenuity Pathway Analysis Canonical Pathways 
IPA Comparison 
Canonical 
Pathway 
Genes 
Represented 
Pathway 
P-value 
BVDV-PI vs High 
Exposures - All 
Interferon 
Signaling 
ISG15 
OAS1 
1.12 x 10
-3 
 
Activation of IRF by 
Cytosolic PRR 
ISG15 
ZBP1 
3.30 x 10
-3
 
 
Role of PRR in Recognition 
of Bacteria and Viruses 
OAS1 
OAS2 
1.53 x 10
-2
 
 
Hepatic Fibrosis/ Hepatic 
Stellate Cell Activation 
COL8A1 
MYH7 
2.62 x 10
-2
 
 
Cardiomyocyte 
Differentiation via BMP 
Receptors 
MYH7 2.7210
-2
 
BVDV-PIs vs High 
Exposures - Outliers 
Replaced 
Interferon 
Signaling 
ISG15 
OAS1 
9.03 x 10
-4
 
 
Role of PRR in Recognition 
of Bacteria and Viruses 
OAS1 
OAS2 
1.24 x 10
-2
 
 
Hepatic Fibrosis/ Hepatic 
Stellate Cell Activation 
COL8A1 
MYH7 
2.14 x 10
-2
 
 
Agranulocyte Adhesion and 
Diapedesis 
CCL8 
MYH7 
2.27 x 10
-2
 
 
Cardiomyocyte 
Differentiation via BMP 
Receptors 
MYH7 2.45 x 10
-2
 
BVDV-PIs vs High 
Exposures - Outliers 
Replaced and 
Transcripts 
Manually 
Normalized 
Interferon 
Signaling 
ISG15 
OAS1 
5.31 x 10
-4
 
 
Role of PRR in Recognition 
of Bacteria and Viruses 
OAS1 
OAS2 
7.42 x 10
-3
 
 
Agranulocyte Adhesion and 
Diapedesis 
CCL8 
MYH7 
1.37 x 10
-2
 
 
Cardiomyocyte 
Differentiation via BMP 
Receptors 
MYH7 1.89 x 10
-2
 
 
Role of Lipids / Lipid Rafts 
in the Pathogenesis of 
Influenza 
RSAD2 2.02 x 10
-2
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1.4 Table of Ingenuity Pathway Analysis Networks 
IPA Comparison Network Associations Genes Represented 
BVDV-PIs vs 
High Exposures 
- All 
Antimicrobial Response, 
Inflammatory Response, 
Dermatological Diseases and 
Conditions 
ADM, BATF2, C2, CCL8, 
COL8A1, EPCAM, GBP2, ID1, 
IFI44, ISG15, LAMB1, 
LAMC2, MX2, OAS1, OAS2, 
RSAD2, SIGLEC1, ZBP1, TG, 
TIMD4 
 
Carbohydrate Metabolism, 
Molecular Transport, 
Small Molecule 
Biochemistry 
ADRB3, APP, CMPK2, EEF2K, 
ESR1, FAM3B, GAS2, HSPA6, 
MYH7, NDRG2, NTHL1, 
PDK4, PLEKHA4, PRKAA1, 
RAMP3, RGS19, RTP4, 
SLCO2B1, TP53 
 
Cell Morphology, 
Reproductive System 
Development and Function, 
Drug Metabolism 
ATP8B4, TMEM30A 
BVDV-PIs vs 
High Exposures 
- Outliers 
Removed 
Antimicrobial Response, 
Inflammatory Response, 
Cell Signaling 
ADM, BATF2, C2, CCL8, 
CTRAC1, DES, EPCAM, 
FAM3B, HSPA6, IFI44, ISG15, 
LAMB1, MX2, OAS1, OAS2, 
RSAD2, SIGLEC1, SLCO2B1, 
TG, TIMD4 
 
Cardiac Hypertrophy, 
Cardiovascular Disease, 
Developmental Disorder 
B3GALT2, CMPK2, COL8A1, 
CPT1A, HBD, IL1B, IL1R2, 
LITAF, MARCKSL1, MYH7, 
PLEKHA4, SIGLEC1, 
SLCO2B1, ST3GLA5, TG, 
TGFB1, TMEM259, TNF 
BVDV-PIs vs 
High Exposures 
- Outliers 
Removed and 
Transcripts 
Manually 
Normalized 
Antimicrobial Response, 
Inflammatory Response, 
Dermatological Diseases and 
Conditions 
ADM, BATF2, CALCRL, 
CCL8, CTRAC1, FAM3B, 
IFI44, ISG15, MX2, OAS1, 
OAS2, RSAD2, SIGLEC1, 
SLCO2B1, TIMD4 
 
Cell Morphology, 
Hematological System 
Development and Function, 
Cell to Cell Signaling and 
Interaction 
ARID5B, B3GALT2, C2, 
CCR3, CMPK2, GBP1, HBD, 
IL1B, LGMN, LITAF, MYH7, 
NLRX1, OAS2, PLEKHA4, 
RNASE1, RNASEL, SIGLEC1, 
SLCO2B1, SORD, ST3GLA5, 
TGFB1, TMEM173, 
TMEM259, TNF 
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1.5 Table of Transcript Counts Manually Normalized 
Ensembl Transcript ID Library ID Original Count Normalized Count 
ENSBTAT00000018757 9 400.35 56.37 
ENSBTAT00000032398 33 160.88 0.53 
 40 224.23 0.53 
ENSBTAT00000018159 10 73.88 24.25 
 40 688.98 25.35 
ENSBTAT00000015166 48 87 28.50 
 40 600.49 27.63 
ENSBTAT00000045468 22 429.73 54.27 
ENSBTAT00000028036 9 222.26 48.56 
 47 12.63 4.37 
ENSBTAT00000037545 48 94439.2 10651.67 
 43 89094.2 10651.67 
 9 82497.6 10651.67 
ENSBTAT00000022034 48 94438.4 10651.76 
 43 89094.8 10651.76 
 9 82492.9 10651.76 
ENSBTAT00000008487 17 145.02 45.64 
 38 157.04 45.64 
 40 708.71 99.13 
ENSBTAT00000045436 27 342.00 130.46 
ENSBTAT00000009798 27 8792.16 2923.69 
 31 8178.94 2923.69 
ENSBTAT00000004093 13 3355.23 441.16 
ENSBTAT00000004444 10 5338.54 1314.94 
 9 5710.67 1314.94 
 13 1127.47 163.72 
ENSBTAT00000019477 9 29605.6 8215.99 
 47 6833.86 790.89 
ENSBTAT00000016856 9 81221.1 30816.04 
 47 20340.3 3433.09 
ENSBTAT00000002019 48 36453.4 9187.12 
ENSBTAT00000044986 48 38729.2 13653.55 
ENSBTAT00000045694 43 374753 60559.29 
ENSBTAT00000063938 48 121.3 7.50 
 45 642.44 44.23 
ENSBTAT00000057360 44 167.82 9.30 
 17 186.88 9.30 
 47 540.00 78.79 
ENSBTAT00000001496 38 1514.9 119.71 
ENSBTAT00000019573 43 70485.1 23321 
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 47 27914.3 2968.25 
ENSBTAT00000020716 9 828.09 126.97 
ENSBTAT00000048651 47 7408.54 1109.53 
ENSBTAT00000010659 48 268 19.80 
ENSBTAT00000021373 48 53437.9 16929.09 
 47 18359.4 1709.98 
ENSBTAT00000026613 48 14580.7 4491.77 
 47 3962.15 803.17 
ENSBTAT00000043762 9 1885.11 760.06 
 47 922.29 111.43 
ENSBTAT00000011146 48 82874.5 24677.51 
 9 79519.8 24677.51 
 47 20272.9 4457.32 
ENSBTAT00000022376 10 215.57 8.28 
 33 944.84 37.00 
ENSBTAT00000017523 9 4756.06 1203.87 
 47 1092 162.13 
ENSBTAT00000015014 27 1560.59 663.75 
ENSBTAT00000061135 10 146 39.05 
 13 24 6.75 
ENSBTAT00000012124 9 2617.21 786.37 
ENSBTAT00000066038 43 15049.1 5356.84 
 9 15160.5 5356.84 
 47 6467.63 828.23 
ENSBTAT00000030444 9 89170.4 25870.27 
ENSBTAT00000022896 9 7598.2 1553.30 
ENSBTAT00000007041 22 134.01 12.58 
 40 342.01 22.63 
ENSBTAT00000010295 38 747.07 124.35 
 40 214064 142.50 
ENSBTAT00000015237 27 1103.18 389.91 
 13 311.01 95.77 
ENSBTAT00000015085 50 1314.58 49.75 
 47 655.73 46.92 
ENSBTAT00000061306 22 210.74 9.79 
 40 1849.96 44.46 
ENSBTAT00000051987 41 175.80 4.80 
ENSBTAT00000042779 9 160 34.90 
 47 38 4.75 
ENSBTAT00000017547 43 109.04 33.3 
ENSBTAT00000048087 34 109.55 4.65 
 47 276.96 53.60 
ENSBTAT00000057306 17 144.69 6.59 
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 44 120.21 6.59 
 47 376.43 61.17 
ENSBTAT00000057500 37 551.96 171.27 
 47 11142.9 208.45 
ENSBTAT00000030625 48 153.15 25.40 
 17 101.98 25.40 
 13 2044.27 73.13 
ENSBTAT00000046532 48 137.27 39.46 
 30 4342.71 159.55 
ENSBTAT00000065672 38 103.05 46.56 
 47 5268.05 62.83 
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APPENDIX B 
1.0 Script for Trimming and Quality Assessment 
 
This script runs Trim Galore! and trims the fastq pair files for each library. The 
TrimGalorePrime.txt file contains a list of the pair files with the first half of the pair in a 
single column and the complementary half in a second column of the same row with a 
single space separating the two columns. 
 
 
 
1.1 Script for Tophat Filtering Alignment 
 
 
This script utilizes Tophat 2.1 to align the reads to the 
Bos_taurus.UMD3.1.82_MT_RRNA.gtf file in order to filter out any rRNA and mtRNA 
reads. The Read_Files.txt contains a list of the pair files with the first half of the pair in a 
single column and the complementary half in a second column of the same row with a 
single space separating the two columns. 
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1.2 Script for Sorting and Splitting 
 
 
 
This script was utilized to sort the Tophat 2.1 unmapped.bam files and then to split them 
back into pair fastq files for each library and lane. The list.txt file contains a single 
column of the library and lane name ex LIB14004_L001. 
 
 
 
1.3 Script for Tophat Alignment 
 
 
 
This script used Tophat 2.1 to align the paired fastq files for each library to the UMD3.1 
bovine genome with the complete GTF file for annotation. The read_files.txt file 
consisted of a list of the file names with the first half of the pair in the first column and 
the second half in a second column on the same row. This script was run in parallel with 
multiple ranges for the array input in order to decrease run time. 
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1.4 Script for Salmon Transcript Quantification 
 
 
 
This script utilized Salmon to quantify transcripts from the Tophat 2.1 aligned fastq 
reads. The Salmonfiles.txt file lists all four pair files in order by lane for each library ex. 
LIB14050_L001_end1.fq LIB14050_L002_end1.fq LIB14050_L003_end1.fq 
LIB14050_L004_end1.fq LIB14050_L001_end2.fq LIB14050_L002_end2.fq 
LIB14050_L003_end2.fq LIB14050_L004_end2.fq. 
 
 
 
1.5 Script for edgeR Biological Coefficient of Variation Plot 
 
 
 
The input file for this script was called Salmon.csv which contains all of the transcript 
counts from each animal in a column/animal. 
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1.6 Script for edgeR ANOVA  
 
 
This script is run after running the previous edgeR script (1.5) and produces a csv file 
with the comparison results. It is suggest to run one comparison at a time for ease of 
reading the results. 
